Evidence map›Paper›PMID 25589645›Full record

ArticleJournal of virology2015

Long-term control of simian immunodeficiency virus (SIV) in cynomolgus macaques not associated with efficient SIV-specific CD8+ T-cell responses.

Timothée Bruel, Chiraz Hamimi, Nathalie Dereuddre-Bosquet, Antonio Cosma, So Youn Shin, Aurélien Corneau, Pierre Versmisse, Ingrid Karlsson, Benoit Malleret, Brice Targat and 5 more

Abstract read
In one paragraph

Article in Journal of virology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Modeling Kick-Kill Strategies toward HIV Cure.Frontiers in immunology · 2017
    Review
  11. Diversity of Human and Macaque Airway Immune Cells at Baseline and during Tuberculosis Infection.American journal of respiratory cell and molecular biology · 2016
    Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Timothée BruelCommissariat à l'Energie Atomique et aux Energies Alternatives (CEA), Division of Immuno-Virology, Institute of Emerging Diseases and Innovative Therapies, IDMIT Center, Fontenay-aux-Roses, France Université Paris-Sud, Unité Mixte de Recherche UMR-E01, Orsay, France.
Chiraz HamimiInstitut Pasteur, Unité Régulation des Infections Rétrovirales, Paris, France Université Pierre et Marie Curie, Cellule Pasteur UPMC, Paris, France.
Nathalie Dereuddre-BosquetCommissariat à l'Energie Atomique et aux Energies Alternatives (CEA), Division of Immuno-Virology, Institute of Emerging Diseases and Innovative Therapies, IDMIT Center, Fontenay-aux-Roses, France Université Paris-Sud, Unité Mixte de Recherche UMR-E01, Orsay, France.
Antonio CosmaCommissariat à l'Energie Atomique et aux Energies Alternatives (CEA), Division of Immuno-Virology, Institute of Emerging Diseases and Innovative Therapies, IDMIT Center, Fontenay-aux-Roses, France Université Paris-Sud, Unité Mixte de Recherche UMR-E01, Orsay, France.
So Youn ShinInstitut Pasteur, Unité Régulation des Infections Rétrovirales, Paris, France.
Aurélien CorneauCommissariat à l'Energie Atomique et aux Energies Alternatives (CEA), Division of Immuno-Virology, Institute of Emerging Diseases and Innovative Therapies, IDMIT Center, Fontenay-aux-Roses, France Université Paris-Sud, Unité Mixte de Recherche UMR-E01, Orsay, France.
Pierre VersmisseInstitut Pasteur, Unité Régulation des Infections Rétrovirales, Paris, France.
Ingrid KarlssonCommissariat à l'Energie Atomique et aux Energies Alternatives (CEA), Division of Immuno-Virology, Institute of Emerging Diseases and Innovative Therapies, IDMIT Center, Fontenay-aux-Roses, France.
Benoit MalleretCommissariat à l'Energie Atomique et aux Energies Alternatives (CEA), Division of Immuno-Virology, Institute of Emerging Diseases and Innovative Therapies, IDMIT Center, Fontenay-aux-Roses, France.
Brice TargatCommissariat à l'Energie Atomique et aux Energies Alternatives (CEA), Division of Immuno-Virology, Institute of Emerging Diseases and Innovative Therapies, IDMIT Center, Fontenay-aux-Roses, France Université Paris-Sud, Unité Mixte de Recherche UMR-E01, Orsay, France.
Françoise Barré-SinoussiInstitut Pasteur, Unité Régulation des Infections Rétrovirales, Paris, France.
Roger Le GrandCommissariat à l'Energie Atomique et aux Energies Alternatives (CEA), Division of Immuno-Virology, Institute of Emerging Diseases and Innovative Therapies, IDMIT Center, Fontenay-aux-Roses, France Université Paris-Sud, Unité Mixte de Recherche UMR-E01, Orsay, France.
Gianfranco PancinoInstitut Pasteur, Unité Régulation des Infections Rétrovirales, Paris, France.
Asier Sáez-CiriónInstitut Pasteur, Unité Régulation des Infections Rétrovirales, Paris, France bruno.vaslin@cea.fr asier.saez-cirion@pasteur.fr.
Bruno VaslinCommissariat à l'Energie Atomique et aux Energies Alternatives (CEA), Division of Immuno-Virology, Institute of Emerging Diseases and Innovative Therapies, IDMIT Center, Fontenay-aux-Roses, France Université Paris-Sud, Unité Mixte de Recherche UMR-E01, Orsay, France bruno.vaslin@cea.fr asier.saez-cirion@pasteur.fr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

unlabelledThe spontaneous control of human and simian immunodeficiency viruses (HIV/SIV) is typically associated with specific major histocompatibility complex (MHC) class I alleles and efficient CD8(+) T-cell responses, but many controllers maintain viral control despite a nonprotective MHC background and weak CD8(+) T-cell responses. Therefore, the contribution of this response to maintaining long-term viral control remains unclear. To address this question, we transiently depleted CD8(+) T cells from five SIV-infected cynomolgus macaques with long-term viral control and weak CD8(+) T-cell responses. Among them, only one carried the protective MHC allele H6. After depletion, four of five controllers experienced a transient rebound of viremia. The return to undetectable viremia was accompanied by only modest expansion of SIV-specific CD8(+) T cells that lacked efficient SIV suppression capacity ex vivo. In contrast, the depletion was associated with homeostatic activation/expansion of CD4(+) T cells that correlated with viral rebound. In one macaque, viremia remained undetectable despite efficient CD8(+) cell depletion and inducible SIV replication from its CD4(+) T cells in vitro. Altogether, our results suggest that CD8(+) T cells are not unique contributors to the long-term maintenance of low viremia in this SIV controller model and that other mechanisms, such as weak viral reservoirs or control of activation, may be important players in control. IMPORTANCE: Spontaneous control of HIV-1 to undetectable levels is associated with efficient anti-HIV CD8(+) T-cell responses. However, in some cases, this response fades over time, although viral control is maintained, and many HIV controllers (weak responders) have very low frequencies of HIV-specific CD8(+) T cells. In these cases, the importance of CD8 T cells in the maintenance of HIV-1 control is questionable. We developed a nonhuman primate model of durable SIV control with an immune profile resembling that of weak responders. Transient depletion of CD8(+) cells induced a rise in the viral load. However, viremia was correlated with CD4(+) T-cell activation subsequent to CD8(+) cell depletion. Regain of viral control to predepletion levels was not associated with restoration of the anti-SIV capacities of CD8(+) T cells. Our results suggest that CD8(+) T cells may not be involved in maintenance of viral control in weak responders and highlight the fact that additional mechanisms should not be underestimated.

Indexed as

AnimalsCD8-Positive T-LymphocytesLeukocyte Reduction ProceduresMacaca fascicularisSimian Acquired Immunodeficiency SyndromeSimian Immunodeficiency VirusSurvivorsViral Load

Identifiers

PMID25589645
PMCPMC4403397

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.